Skip to content

Kangyi Qiangshen Gong exercise prescription for pulmonary function and quality of life in patients recovered from COVID-19: a randomized controlled trial

Kangyi Qiangshen Gong exercise prescription for pulmonary function and quality of life in patients recovered from COVID-19: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005963
Enrollment
Unknown
Registered
2022-05-03
Start date
2022-05-10
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel coronavirus Pneumonia (COVID-19)

Interventions

the breathing techniques (BT) group:breathing techniques (BT)
the Kangyi Qiangshen Gong exercise prescription (KQG) group:Kangyi Qiangshen Gong exercise prescription (KQG)

Sponsors

School of Acupuncture-moxibustion and Tuina, Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Discharged patients with COVID-19; (2) Are male or female between the ages of 20 and 80; (3) Have post-COVID-19 symptoms include but not limited to breath difficulties, fatigue, sleep difficulties, anxiety or depression; (4) Have a stable condition and remain conscious and cooperative during trial; (5) Willing to join the trial and signed the informed consent form; (6) Promise not to participate in other forms of exercise.

Exclusion criteria

Exclusion criteria: (1) Patients with complications of underlying noncommunicable diseases such as chronic obstructive pulmonary disease, coronary heart disease, dementia, chronic kidney disease, immunosuppression and cancer; (2) Patients with mental illness; (3) Patients with cognitive dysfunction until unable to understand the whole trial process; (4) Patients with severe bone or joint diseases that affect movement (eg. spinal arthritis, severe osteoporosis, and periarthritis); (5) Patients with pregnancy or lactating; (6) Cigarettes Smokers; (7) Patients who participate in other form of exercise programs during trial.

Design outcomes

Primary

MeasureTime frame
Modified Medical Research Council (mMRC) dyspnoea scale;

Secondary

MeasureTime frame
Fatigue Scale-14;PSQI;Patient Health Questionnaire-9 Scale;Respiratory Symptoms Scale;Modified Borg Scale;

Countries

China

Contacts

Public ContactFang Min
fm-tn0510@shutcm.edu.cn+86 18930568005

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026